Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury—Reply
In Reply We thank Dr Hemilä and Ms Chalker for their interest in our VICTORY trial. They propose that the increased mortality in the vitamin C group reflected a rebound effect following abrupt discontinuation of therapy after 96 hours, rather than a direct effect of the drug itself. While one can never definitively rule out that different timing or dosing of a treatment could result in different outcomes, based on a post hoc analysis of the precise timing of treatment and subsequent mortality, we do not believe the VICTORY study provides evidence to suggest that the higher mortality rate observed in the vitamin C group was due to its abrupt termination.